Invicta Diagnos.

Why is Invicta Diagnostic Ltd falling/rising?

As of 24-Aug, Invicta Diagnostic Ltd's stock price is currently at 70.00, reflecting a slight increase despite a recent decline over the past week. The stock has gained 9.80% over the past month, but decreased investor participation and mixed moving average performance indicate potential volatility and lack of sustained confidence.

As of 24-Aug, Invicta Diagnostic Ltd's stock price is rising, currently at 70.00, reflecting a change of 0.5 (0.72%) upward. This increase occurs despite a recent decline over the past week, where the stock fell by 4.11%, contrasting with a minor decline in the benchmark Sensex of only 0.28%. Over the past month, however, the stock has shown a positive trend, gaining 9.80%, significantly outperforming the Sensex's increase of 1.90%.<BR><BR>Today's performance is reported as inline with the sector, and while the stock is currently higher than its 50-day moving average, it remains below the 5-day, 20-day, 100-day, and 200-day moving averages. This suggests some volatility in the stock's performance relative to its longer-term trends. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 67.74% against the 5-day average, indicating reduced trading activity.<BR><BR>Overall, while the stock is experiencing a rise today, the context of falling investor participation and mixed moving average performance suggests that the upward movement may be influenced by short-term factors rather than sustained investor confidence.

Which are the latest news on Invicta Diagnos.?

What does Invicta Diagnos. do?

Invicta Diagnostic Ltd is a micro-cap healthcare services company incorporated in 2021, recently transitioning to a Private Limited Company. It currently has no available revenue or profit data, with a market cap of INR 92 Cr and a P/E ratio of 19.00.

Overview:<BR>Invicta Diagnostic Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Invicta Diagnostic Ltd was incorporated in 2021 as a Limited Liability Partnership under the name "Invicta Diagnostic LLP." It transitioned to a Private Limited Company on December 01, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 92 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00<BR>Industry P/E: 67<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.37<BR>Return on Equity: 9.84%<BR>Price-to-Book: 1.84<BR><BR>Contact Details:<BR>Address: Not available<BR>Phone: N/A<BR>Email: N/A<BR>Website: N/A

Who are the peers of the Invicta Diagnos.?

Invicta Diagnos.' peers include Bilcare, Aakaar Medical, Aspira Pathlab, Choksi Laborator, Jeevan Scienti., Shree Pacetronix, Star Imaging, and Royal Sense. Royal Sense shows the highest 1-year return, while Aakaar Medical has the lowest at -39.10%.

Peers: The peers of Invicta Diagnos. are Bilcare, Aakaar Medical, Aspira Pathlab, Choksi Laborator, Jeevan Scienti., Shree Pacetronix, Star Imaging, and Royal Sense.<BR><BR>Quality Snapshot: Excellent management risk is observed at Aakaar Medical, Shree Pacetronix, Star Imaging, and Royal Sense, while Good management risk is found at the same companies. Below Average management risk is noted at Bilcare, Aspira Pathlab, Choksi Laborator, and Jeevan Scienti. For Growth, Excellent growth is seen at Royal Sense, while Good growth is noted at Aakaar Medical, Choksi Laborator, Shree Pacetronix, and the rest. Below Average growth is present at Bilcare, Aspira Pathlab, Jeevan Scienti., and the rest. Average capital structure is observed at Aspira Pathlab and Jeevan Scienti., while Below Average capital structure is found at Bilcare, Choksi Laborator, and the rest. Good capital structure is noted at Aakaar Medical, Shree Pacetronix, and Royal Sense.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Royal Sense with an Excellent return, while Aakaar Medical has the lowest at -39.10%. Invicta Diagnos. does not have a reported 1-year return. Additionally, Aakaar Medical is the only peer with a negative six-month return at 11.15%.

How big is Invicta Diagnos.?

As of 13th August, Invicta Diagnostic Ltd has a market capitalization of 92.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 16.83 Cr and Total Assets of 21.25 Cr reported as of March 2025. There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 13th August, <BR><BR>Market Cap: Invicta Diagnostic Ltd has a market capitalization of 92.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 16.83 Cr and Total Assets valued at 21.25 Cr.